Open AccessAbstract 2878: CRISPR-Cas9 screens identify the nuclear export factor NXT1 as a novel therapeutic target inMYCN-amplified neuroblastoma
Author(s) -
Clare F. Malone,
Neekesh V. Dharia,
Guillaume Kugener,
Brenton R. Paolella,
Michael B. Rothberg,
Mai Abdusamad,
Alfredo Bullard González,
Nancy Dumont,
Scott T. Younger,
David E. Root,
Francisca Vázquez,
Kimberly Stegmaier
Publication year - 2019
Publication title -
tumor biology
Language(s) - English
Resource type - Conference proceedings
SCImago Journal Rank - 1.055
H-Index - 84
eISSN - 1423-0380
pISSN - 1010-4283
DOI - 10.1158/1538-7445.sabcs18-2878
Subject(s) - crispr , cas9 , neuroblastoma , biology , cancer research , genetics , gene , cell culture